126 related articles for article (PubMed ID: 3774260)
1. The influence of hypercholesterolaemia on the adrenal uptake and metabolic handling of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59).
Lynn MD; Gross MD; Shapiro B; Bassett D
Nucl Med Commun; 1986 Aug; 7(8):631-7. PubMed ID: 3774260
[TBL] [Abstract][Full Text] [Related]
2. Enterohepatic circulation and distribution of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59).
Lynn MD; Gross MD; Shapiro B
Nucl Med Commun; 1986 Aug; 7(8):625-30. PubMed ID: 3774259
[TBL] [Abstract][Full Text] [Related]
3. The relationship of I-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal cortical uptake to indices of androgen secretion in women with hyperandrogenism.
Gross MD; Shapiro B; Freitas JE; Ayers J; Swanson DP; Woodbury MC; Schteingart DE; Beierwaltes WH
Clin Nucl Med; 1984 May; 9(5):264-70. PubMed ID: 6235079
[TBL] [Abstract][Full Text] [Related]
4. Value of bowel preparation in adrenocortical scintigraphy with NP-59.
Shapiro B; Nakajo M; Gross MD; Freitas J; Copp J; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):732-4. PubMed ID: 6875684
[TBL] [Abstract][Full Text] [Related]
5. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
[TBL] [Abstract][Full Text] [Related]
6. [Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats].
Ito T; Ogawa H; Maeda M; Kojima M
Yakugaku Zasshi; 1983 Jun; 103(6):644-9. PubMed ID: 6655551
[No Abstract] [Full Text] [Related]
7. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
8. Positive iodine-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal images can precede return of adrenocortical function after o,p' DDD treatment.
Sparagana M; Ackerman L
Clin Nucl Med; 1988 May; 13(5):348-51. PubMed ID: 3390980
[TBL] [Abstract][Full Text] [Related]
9. Case report: failure of adrenal scintigraphy to exhibit 131I cholesterol uptake in a CT-demonstrated, surgically proven aldosteronoma.
Salam Z; Lubbos H; Martinez C; Mozley PD; Miller JL; Rose LI
Am J Med Sci; 1996 Sep; 312(3):130-2. PubMed ID: 8783680
[TBL] [Abstract][Full Text] [Related]
10. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
[TBL] [Abstract][Full Text] [Related]
11. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
[No Abstract] [Full Text] [Related]
12. [Adrenal scintigraphy with 131I-6beta-iodomethyl-19-norcholesterol: good practice guideline].
Bardet S; Nocaudie-Calzada M; Kraimps JL; Tabarin A; Wémeau JL
Ann Endocrinol (Paris); 1998 Nov; 59(4):344-53. PubMed ID: 9864556
[TBL] [Abstract][Full Text] [Related]
13. A new and superior adrenal scanning agent, NP-59.
Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
[TBL] [Abstract][Full Text] [Related]
14. Adrenal cortical imaging with I-131 NP-59 SPECT-CT.
Wong KK; Komissarova M; Avram AM; Fig LM; Gross MD
Clin Nucl Med; 2010 Nov; 35(11):865-9. PubMed ID: 20940544
[TBL] [Abstract][Full Text] [Related]
15. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas.
Imperiale A; Olianti C; Mannelli M; La Cava G; Pupi A
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):287-96. PubMed ID: 16172575
[TBL] [Abstract][Full Text] [Related]
16. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
Sarkar SD; Cohen EL; Beierwaltes WH; Ice RD; Cooper R; Gold EN
J Clin Endocrinol Metab; 1977 Aug; 45(2):353-62. PubMed ID: 885997
[TBL] [Abstract][Full Text] [Related]
17. Imaging the adrenal cortex: why and wherefore?
Britton KE
Nucl Med Commun; 1992 Jul; 13(7):485-7. PubMed ID: 1495676
[No Abstract] [Full Text] [Related]
18. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
[TBL] [Abstract][Full Text] [Related]
19. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
Ryo UY; Johnston AS; Kim I; Pinsky SM
Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan.
Wu MH; Liu FH; Lin KJ; Sun JH; Chen ST
Nucl Med Commun; 2019 Jun; 40(6):568-575. PubMed ID: 30694876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
